Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.1275 0 (0%) Market Cap: 20.04 Bil Enterprise Value: 23.95 Bil PE Ratio: 56.39 PB Ratio: 2.01 GF Score: 87/100

Q2 2022 Astellas Pharma Inc Earnings Presentation Transcript

Oct 29, 2021 / 05:00AM GMT
Release Date Price: $16.41 (-3.47%)

Oct 29, 2021 / 05:00AM GMT
Presentation
Oct 29, 2021 / 05:00AM GMT

=====================
Corporate Participants
=====================
* Bernhardt G. Zeiher
Astellas Pharma Inc. - Chief Medical Officer & President of Development
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, CFO, Chief Strategy Officer, Chief Business Officer & Representative Director
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot